Press release
10 May 2023
Cellular Goods PLC
('Cellular Goods' or 'the Company')
Products to launch on Sephora.co.uk
Cellular Goods (LSE: CBX), a UK-based skincare and wellness company providing premium consumer products formulated with lab-produced cannabinoids, is pleased to announce that it has entered into a contract with multinational beauty and cosmetics retailer Sephora to make the Company's 'Look Better' (skincare) range available for purchase on Sephora's e-commerce website, Sephora.co.uk from the second half of May.
Cellular Goods will become the first cannabigerol (CBG)-based skincare brand to offer its products on Sephora UK, as part of the Company's enhanced retail strategy to drive growth by expanding its sales channels and increasing its collaboration with established online and high street outlets.
Sephora.co.uk will stock the full range of the Company's facial skincare products including the brand's best-selling Rejuvenating Face Serum, designed to visibly reverse signs of skin ageing, whilst also protecting from inflammation and irritation. Cellular Goods' newest range of skincare products, the Rejuvenating Night Cream, SPF 25 Rejuvenating Day Cream and Rejuvenating Day Mousse, containing the Company's proprietary formulation of CBG and CBD, will also be available on the website.
Additional Cellular Goods products available on Sephora.co.uk include the Company's CBG-based Nourishing Cannabinoid Face Oil, and Calming Cannabinoid After Shaving Moisturiser, as well as selected 'mini' sizes and gifting products during seasonal moments.
Darcy Taylor, Chairman and Interim CEO of Cellular Goods, commented: "I'm delighted that our products will be going on sale at Sephora.co.uk. The launch bridges the gap between customer awareness and sales by making it easier for customers to purchase our products. We're confident that our effective next-generation skincare formulations will appeal to their existing customers and encourage them to try our CBG-powered products. The Sephora launch is part of our continued customer acquisition strategy, as we continue to increase awareness of our products and grow our sales channels."
For further information please contact:
| Cellular Goods | |
| Darcy Taylor Chairman and interim CEO Neil Thapar Investor Relations | via Tancredi +44 207 887 7633
+44 787 645 5323 |
| First Sentinel Corporate Finance | |
| Corporate Broker & Advisor Brian Stockbridge |
+44 7876 888 011 |
| Novum Securities |
|
| Corporate Broker Colin Rowbury Jon Belliss |
+44 207 399 9427 |
| Tancredi Intelligent Communication | |
| Media Relations Helen Humphrey Charlie Hobbs |
+44 744 922 6720 +44 789 755 7112 |
About Cellular Goods PLC:
Cellular Goods develops and markets premium quality skincare and wellness products based on proprietary formulations incorporating biosynthetic lab-made cannabinoids. Our branded products are efficacy-led and research-backed and available online in the UK and US. The Company is incorporated in the UK and listed on the Main Market of the London Stock Exchange. For more information, visit www.cellular-goods.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.